|
GS135951: HDL QTL 19 (Hdlq19, Published QTL Chr 2)
|
|
GS866: Linear decrease in expression in both Pax6 (Sey) mutants and controls.
|
|
GS123297: Acetylcholine interacting genes (MeSH:D000109) in CTD
|
|
GS123554: vinclozolin interacting genes (MeSH:C025643) in CTD
|
|
GS135808: erosive arthritis susceptibility 1 (Erars1, Published QTL Chr 2)
|
|
GS208901: GO:0005859 muscle myosin complex
|
|
GS204996: GO:0048858 cell projection morphogenesis
|
|
GS135915: gestational survival modifier locus (Gstml, Published QTL Chr 2)
|
|
GS136811: total cholesterol QTL 2 (Tcq2, Published QTL Chr 2)
|
|
GS205144: GO:0048468 cell development
|
|
GS201949: GO:0044699 single-organism process
|
|
GS135515: "body weight, QTL 5" (Bwq5, Published QTL Chr 2)
|
|
GS123718: Ethinyl Estradiol interacting genes (MeSH:D004997) in CTD
|
|
GS204425: GO:0048812 neuron projection morphogenesis
|
|
GS135345: atherosclerotic lesion area 1 (Athla1, Published QTL Chr 2)
|
|
GS209569: GO:0048667 cell morphogenesis involved in neuron differentiation
|
|
GS189317: GO:0043292 contractile fiber
|
|
GS136010: hemotopoietic response to early cytokines (Hrec, Published QTL Chr 2)
|
|
GS135927: hepatocarcinogenesis susceptibility 4 (Hcs4, Published QTL Chr 2)
|
|
GS121888: methylselenic acid interacting genes (MeSH:C008493) in CTD
|
|
GS193061: GO:0044444 cytoplasmic part
|
|
GS182834: GO:0005623 cell
|
|
GS192041: GO:0043169 cation binding
|
|
GS196002: GO:0048699 generation of neurons
|
|
GS197016: GO:0032991 macromolecular complex
|
|
GS194028: GO:0032432 actin filament bundle
|
|
GS182474: GO:0043232 intracellular non-membrane-bounded organelle
|
|
GS199635: GO:0005622 intracellular
|
|
GS135407: body growth late QTL 2 (Bglq2, Published QTL Chr 2)
|
|
GS136888: voluntary alcohol consumption QTL 1 (Vacq1, Published QTL Chr 2)
|
|
GS193268: GO:0005575 cellular_component
|
|
GS207365: GO:0005829 cytosol
|
|
GS35452: Striatum Gene expression correlates of Difference in total distance traveled (cm) (saline-ethanol) in Females & Males BXD
|
|
GS84135: cocaine related behavior (Published QTL, Chr 2)
|
|
GS1229: Differential gene expression among both the Heroin and Cocaine Abusers
|
|
GS202940: GO:0006935 chemotaxis
|
|
GS207797: GO:0030154 cell differentiation
|
|
GS135377: body length QTL 7 (Bdlnq7, Published QTL Chr 2)
|
|
GS207581: GO:0007275 multicellular organismal development
|
|
GS121437: Fluorouracil interacting genes (MeSH:D005472) in CTD
|
|
GS136132: lithogenic gene 12 (Lith12, Published QTL Chr 2)
|
|
GS136493: proteoglycan induced arthritis 2 (Pgia2, Published QTL Chr 2)
|
|
GS122142: Dietary Fats interacting genes (MeSH:D004041) in CTD
|
|
GS136535: promotion susceptibility QTL 2 (Psl2, Published QTL Chr 2)
|
|
GS196941: GO:0008150 biological_process
|
|
GS205002: GO:0048856 anatomical structure development
|
|
GS199634: GO:0005623 cell
|
|
GS208922: GO:0030017 sarcomere
|
|
GS205610: GO:0044430 cytoskeletal part
|
|
GS123595: Progesterone interacting genes (MeSH:D011374) in CTD
|
|
GS180296: GO:0005509 calcium ion binding
|
|
GS188368: GO:0015629 actin cytoskeleton
|
|
GS201256: GO:0044422 organelle part
|
|
GS135604: circulating hormone level QTL 13 (Chlq13, Published QTL Chr 2)
|
|
GS126171: Capsaicin interacting genes (MeSH:D002211) in CTD
|
|
GS183169: GO:0031674 I band
|
|
GS135704: diabetes mRNA cluster 1 (Dbmc1, Published QTL Chr 2)
|
|
GS84138: METH responses for climbing (Published QTL, Chr 2)
|
|
GS126646: Carbon Tetrachloride interacting genes (MeSH:D002251) in CTD
|
|
GS210237: GO:0000902 cell morphogenesis
|
|
GS209411: GO:0048869 cellular developmental process
|
|
GS135287: alcohol response 2 (Alcrsp2, Published QTL Chr 2)
|
|
GS135984: hematocrit QTL 2 (Hemq2, Published QTL Chr 2)
|
|
GS191106: GO:0044464 cell part
|
|
GS191954: GO:0005856 cytoskeleton
|
|
GS205224: GO:0015629 actin cytoskeleton
|
|
GS136018: heart failure modifier 5 (Hrtfm5, Published QTL Chr 2)
|
|
GS177404: GO:0005737 cytoplasm
|
|
GS199267: GO:0043234 protein complex
|
|
GS208893: GO:0005856 cytoskeleton
|
|
GS201251: GO:0044424 intracellular part
|
|
GS195110: GO:0071842 cellular component organization at cellular level
|
|
GS193059: GO:0044446 intracellular organelle part
|
|
GS181533: GO:0046872 metal ion binding
|
|
GS135767: experimental allergic encephalomyelitis susceptibility 8 (Eae8, Published QTL Chr 2)
|
|
GS135502: bladder tumor susceptibility 1 (Bts1, Published QTL Chr 2)
|
|
GS136639: salmonella enteritidis susceptibility 7 (Ses7, Published QTL Chr 2)
|
|
GS204095: GO:0030182 neuron differentiation
|
|
GS136417: orthodenticle homolog 2 (Drosophila) modifier 2 (Otx2m2, Published QTL Chr 2)
|
|
GS125062: palm oil interacting genes (MeSH:C041786) in CTD
|
|
GS199272: GO:0043232 intracellular non-membrane-bounded organelle
|
|
GS197076: GO:0005509 calcium ion binding
|
|
GS202941: GO:0006936 muscle contraction
|
|
GS121893: Vitamin E interacting genes (MeSH:D014810) in CTD
|
|
GS204021: GO:0044707 single-multicellular organism process
|
|
GS193195: GO:0016460 myosin II complex
|
|
GS210236: GO:0000904 cell morphogenesis involved in differentiation
|
|
GS129086: blood glucose level 1 (Bglu1 Published QTL Chr 2)
|
|
GS127240: Acetaminophen interacting genes (MeSH:D000082) in CTD
|
|
GS197017: GO:0032990 cell part morphogenesis
|
|
GS197028: GO:0016459 myosin complex
|
|
GS208928: GO:0030018 Z disc
|
|
GS129170: prion disease incubation time 2 (Prdt2 Published QTL Chr 2)
|
|
GS208978: GO:0043169 cation binding
|
|
GS209568: GO:0048666 neuron development
|
|
GS194455: GO:0051239 regulation of multicellular organismal process
|
|
GS135373: body length 3 (Bdln3, Published QTL Chr 2)
|
|
GS135236: activity response to ethanol 3 (Actre3, Published QTL Chr 2)
|
|
GS136885: urinary albuminuria 1 (Ua1, Published QTL Chr 2)
|
|
GS196806: GO:0032502 developmental process
|
|
GS196080: GO:0040011 locomotion
|
|
GS208126: GO:0009605 response to external stimulus
|
|
GS135378: bone density traits 1 (Bdt1, Published QTL Chr 2)
|
|
GS136162: leishmaniasis resistance 16 (Lmr16, Published QTL Chr 2)
|
|
GS203594: GO:0043226 organelle
|
|
GS202919: GO:0001725 stress fiber
|
|
GS135439: bone mineral density 6 (Bmd6, Published QTL Chr 2)
|
|
GS129138: growth and fatness 3 (Gnf3 Published QTL Chr 2)
|
|
GS35504: Neocortex Gene expression correlates of Neurogenesis- BrdU labeled new neurons in Adult Rostral Migratory Stream 1 hr post BrdU in Females BXD
|
|
GS197892: GO:0043228 non-membrane-bounded organelle
|
|
GS210002: GO:0044444 cytoplasmic part
|
|
GS126896: Methylcholanthrene interacting genes (MeSH:D008748) in CTD
|
|
GS210139: GO:0016460 myosin II complex
|
|
GS202795: GO:0007409 axonogenesis
|
|
GS86977: Table S1: All transcripts significantly different in abundance between the majority of heroin subjects and their matched controls [DRG]
provisional
|
|
GS189443: GO:0044449 contractile fiber part
|
|
GS196808: GO:0032501 multicellular organismal process
|
|
GS186744: GO:0043226 organelle
|
|
GS209960: GO:0003008 system process
|
|
GS191989: GO:0030018 Z disc
|
|
GS206312: GO:0044449 contractile fiber part
|
|
GS129180: spontaneous crescentic glomerulonephritis QTL 3 (Scgq3 Published QTL Chr 2)
|
|
GS182835: GO:0005622 intracellular
|
|
GS205439: GO:0031175 neuron projection development
|
|
GS181102: GO:0043228 non-membrane-bounded organelle
|
|
GS127127: Benzo(a)pyrene interacting genes (MeSH:D001564) in CTD
|
|
GS201060: GO:0042330 taxis
|
|
GS135281: "alcohol preference locus 5, male specific" (Alcp5, Published QTL Chr 2)
|
|
GS206183: GO:0043292 contractile fiber
|
|
GS210000: GO:0044446 intracellular organelle part
|
|
GS202316: GO:0050789 regulation of biological process
|
|
GS182576: GO:0042641 actomyosin
|
|
GS194087: GO:0003674 molecular_function
|
|
GS194133: GO:0005737 cytoplasm
|
|
GS203406: GO:0009653 anatomical structure morphogenesis
|
|
GS177356: GO:0003674 molecular_function
|
|
GS203590: GO:0043229 intracellular organelle
|
|
GS121161: Arsenic interacting genes (MeSH:D001151) in CTD
|
|
GS189860: GO:0043167 ion binding
|
|
GS135442: bone marrow graft rejection 3 (Bmgr3, Published QTL Chr 2)
|
|
GS208058: GO:0007411 axon guidance
|
|
GS204054: GO:0044057 regulation of system process
|
|
GS136588: renal disease susceptibility (Rends, Published QTL Chr 2)
|
|
GS127114: Methylnitronitrosoguanidine interacting genes (MeSH:D008769) in CTD
|
|
GS177298: GO:0032432 actin filament bundle
|
|
GS194307: GO:0016043 cellular component organization
|
|
GS209525: GO:0032989 cellular component morphogenesis
|
|
GS206742: GO:0043167 ion binding
|
|
GS198670: GO:0090257 regulation of muscle system process
|
|
GS180248: GO:0016459 myosin complex
|
|
GS83987: cocaine related behavior 3 (Cocrb3, Published QTL, Chr 2)
|
|
GS136192: learning-contextual 10 (Lrnx10, Published QTL Chr 2)
|
|
GS136391: organ weight 1 (Org1, Published QTL Chr 2)
|
|
GS195668: GO:0042221 response to chemical stimulus
|
|
GS127012: Raloxifene interacting genes (MeSH:D020849) in CTD
|
|
GS126584: Tetrachlorodibenzodioxin interacting genes (MeSH:D013749) in CTD
|
|
GS128575: Ethanol induced LORR Chr# 2
|
|
GS136714: susceptibility to lung cancer 17 (Sluc17, Published QTL Chr 2)
|
|
GS181473: GO:0005488 binding
|
|
GS84139: nicotine sensitivity (Published QTL, Chr 2)
|
|
GS196930: GO:0065007 biological regulation
|
|
GS208921: GO:0030016 myofibril
|
|
GS135282: "alcohol preference locus 6, female specific" (Alcp6, Published QTL Chr 2)
|
|
GS195214: GO:0009987 cellular process
|
|
GS129156: multigenic obesity QTL 5 (Mobq5 Published QTL Chr 2)
|
|
GS184452: GO:0044422 organelle part
|
|
GS198004: GO:0007399 nervous system development
|
|
GS195112: GO:0071840 cellular component organization or biogenesis
|
|
GS136842: telomere length QTL 1 (Tlq1, Published QTL Chr 2)
|
|
GS199374: GO:0042641 actomyosin
|
|
GS135311: autoimmune ovarian dysgenesis 4 (Aod4, Published QTL Chr 2)
|
|
GS135903: granulosa cell tumorigenesis 8 (Gct8, Published QTL Chr 2)
|
|
GS193991: GO:0048731 system development
|
|
GS135575: cystic fibrosis lung disease 1 (Cfld1, Published QTL Chr 2)
|
|
GS136915: vertebral morphology and mechanical traits 3 (Vmmt3, Published QTL Chr 2)
|
|
GS199651: GO:0005198 structural molecule activity
|
|
GS198263: GO:0005488 binding
|
|
GS135837: total fat pad mass QTL 1 (Fatmq1, Published QTL Chr 2)
|
|
GS199969: GO:0031674 I band
|
|
GS200809: GO:0030030 cell projection organization
|
|
GS84136: ethanol induced locomotion (Published QTL, Chr 2)
|
|
GS200955: GO:0008307 structural constituent of muscle
|
|
GS136449: postnatal body weight growth 11 (Pbwg11, Published QTL Chr 2)
|
|
GS191982: GO:0030016 myofibril
|
|
GS198323: GO:0046872 metal ion binding
|
|
GS135725: duration of locomotor activity 1 (Dloc1, Published QTL Chr 2)
|
|
GS124312: sodium arsenite interacting genes (MeSH:C017947) in CTD
|
|
GS184447: GO:0044424 intracellular part
|
|
GS205557: GO:0003012 muscle system process
|
|
GS205691: GO:0022008 neurogenesis
|
|
GS136338: nicotine induced locomotor activity 3 (Nilac3, Published QTL Chr 2)
|
|
GS191983: GO:0030017 sarcomere
|
|
GS209863: GO:0050896 response to stimulus
|
|
GS182469: GO:0043234 protein complex
|
|
GS188751: GO:0044430 cytoskeletal part
|
|
GS186740: GO:0043229 intracellular organelle
|
|
GS202942: GO:0006937 regulation of muscle contraction
|
|
GS186087: GO:0001725 stress fiber
|
|
GS196772: GO:0048646 anatomical structure formation involved in morphogenesis
|
|
GS180236: GO:0032991 macromolecular complex
|
|
GS136527: prion disease incubation time 1 (Prdt1, Published QTL Chr 2)
|
|
GS208012: GO:0044464 cell part
|
|
GS210212: GO:0005575 cellular_component
|
|
GS136770: spleen weight QTL 6 (Swq6, Published QTL Chr 2)
|
|
GS136951: weight gain in high growth mice 6 (Wg6, Published QTL Chr 2)
|
|
GS84137: high-dose ethanol actions (Published QTL, Chr 2)
|
|
GS124004: Alendronate interacting genes (MeSH:D019386) in CTD
|
|
GS195113: GO:0071841 cellular component organization or biogenesis at cellular level
|
|
GS34262: Hippocampus Gene expression correlates of Suppression of activity in altered context in Males BXD
|